Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
42.90    7.04 (19.63%)
Bid:
42.92
Ask:
43.08
Spread: 0.16 (0.373%)
Market Cap: £673.52m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Fourth Quarter Trading Statement

10 Jul 2026 07:00

RNS Number : 7888L
Hays PLC
10 July 2026
 

 

Hays plc

Fourth Quarter Trading Statement

 

10 July 2026

Hays plc ('Hays' or the 'Company') today announces its quarterly update for the three months ended 30 June 2026 ('Fourth Quarter Trading Statement'), which is available at: http://www.rns-pdf.londonstockexchange.com/rns/7888L_1-2026-7-9.pdf.

The Fourth Quarter Trading Statement will also be available on the Hays website www.hays.com/investors and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Conference call

James Hilton and Kean Marden will conduct a conference call for analysts and investors at 9:00am UK time on 10 July 2026. Participants are invited to register via the URL link below:

https://register-conf.media-server.com/register/BIb916b49258a944ee8472a23adfe79fbb

 

Once registered, you will receive a confirmation email, with the details of the call and a personal login link and PIN which will place you directly into the call, without the need to speak to an operator. The call will be recorded and will also be available for playback via the results centre on our investor website.

 

Enquiries

Hays plc

 James Hilton

Chief Financial Officer

+44 (0) 203 978 2520

 Kean Marden

Head of Investor Relations & M&A

+44 (0) 333 010 7092

 

 

FGS Global

 Guy Lamming /

hays@fgsglobal.com

 Anjali Unnikrishnan /

 Richard Crowley

 

 

LEI: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKRWRNAUBRAR
Date   Source Headline
20th Feb 20257:00 amRNSHalf Year Report
3rd Feb 202510:15 amRNSBlock listing Interim Review
3rd Feb 202510:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSBoard Changes
15th Jan 20257:00 amRNSSecond Quarter Trading Statement
13th Jan 20252:14 pmRNSDirector Declaration
2nd Jan 202510:50 amRNSHolding(s) in Company
2nd Jan 202510:35 amRNSTotal Voting Rights
17th Dec 20241:00 pmRNSDirector/PDMR Shareholding
16th Dec 20249:17 amRNSDirector/PDMR Shareholding
9th Dec 20242:37 pmRNSDB pension scheme de-risked with full buy-in
2nd Dec 202411:55 amRNSTotal Voting Rights
28th Nov 202412:14 pmRNSDirector/PDMR Shareholding
26th Nov 202411:02 amRNSHolding(s) in Company
20th Nov 20242:27 pmRNSBoard Committee Changes
20th Nov 20242:07 pmRNSResult of AGM
1st Nov 202410:00 amRNSTotal Voting Rights
25th Oct 20242:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20241:49 pmRNSHolding(s) in Company
16th Oct 20242:01 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSFirst Quarter Trading Statement
10th Oct 20244:44 pmRNSDirector/PDMR Shareholding - Amendment
10th Oct 202412:45 pmRNSDirector/PDMR Shareholding
7th Oct 20243:14 pmRNSDirector/PDMR Shareholding
7th Oct 202412:43 pmRNSAnnual Financial Report
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20242:39 pmRNSDirector/PDMR Shareholding
12th Sep 20243:52 pmRNSDirector/PDMR Shareholding
9th Sep 20242:45 pmRNSDirector/PDMR Shareholding
6th Sep 20242:16 pmRNSDirector/PDMR Shareholding
4th Sep 20244:30 pmRNSDirector/PDMR Shareholding
2nd Sep 202410:27 amRNSTotal Voting Rights
22nd Aug 20247:00 amRNSFinal Results
20th Aug 20245:00 pmRNSCompany Secretary Change
20th Aug 20244:02 pmRNSHolding(s) in Company
1st Aug 202410:15 amRNSBlock listing Interim Review
1st Aug 202410:00 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSFourth Quarter Trading Statement
1st Jul 202410:00 amRNSTotal Voting Rights
6th Jun 20243:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:00 amRNSTotal Voting Rights
3rd May 20242:07 pmRNSResponse to Voting Results
1st May 202410:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSThird Quarter Trading Statement
12th Apr 202410:06 amRNSDirector/PDMR Shareholding
9th Apr 202410:22 amRNSHolding(s) in Company
8th Apr 20244:00 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:03 amRNSTotal Voting Rights
28th Mar 202412:20 pmRNSDirector/PDMR Shareholding
20th Mar 20242:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.